Nova Eye Medical Limited
ELXMF
$0.00
-$0.10-98.10%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.23% | 26.26% | 20.48% | 18.22% | 27.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.23% | 26.26% | 20.48% | 18.22% | 27.47% |
| Cost of Revenue | 15.13% | 11.61% | 77.34% | 74.02% | 36.46% |
| Gross Profit | 37.95% | 33.74% | 1.55% | -0.36% | 23.31% |
| SG&A Expenses | 12.90% | 9.46% | 13.55% | 11.42% | 16.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.53% | 1.33% | -7.41% | -9.14% | 3.43% |
| Total Operating Expenses | 11.04% | 7.65% | 17.52% | 15.32% | 15.86% |
| Operating Income | 35.02% | 37.00% | -5.73% | -3.75% | 4.91% |
| Income Before Tax | 37.17% | 39.08% | -12.57% | -10.45% | 4.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 37.17% | 39.08% | -12.57% | -10.45% | 4.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.17% | 39.08% | -12.57% | -10.45% | 4.11% |
| EBIT | 35.02% | 37.00% | -5.73% | -3.75% | 4.91% |
| EBITDA | 35.03% | 37.01% | -173.99% | -168.91% | 4.68% |
| EPS Basic | 49.35% | 50.63% | 8.33% | 10.42% | 19.79% |
| Normalized Basic EPS | 50.00% | 51.02% | 6.67% | 10.00% | 20.00% |
| EPS Diluted | 49.35% | 50.63% | 8.33% | 10.42% | 19.79% |
| Normalized Diluted EPS | 50.00% | 51.02% | 6.67% | 10.00% | 20.00% |
| Average Basic Shares Outstanding | 24.24% | 24.24% | 21.84% | 21.84% | 20.38% |
| Average Diluted Shares Outstanding | 24.24% | 24.24% | 21.84% | 21.84% | 20.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |